EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hybrid Drug Delivery System Designed from Spatiotemporal Hierarchical Controlled-Release Strategy Co-Delivering Rutin and Resveratrol for Coordinated Anti-Tumor Immunotherapy

Weinan Li, Sisi Yan iD, Yingying Gao, Yuhan Fu, Yutong Mei, Yanhong Wang iD, Zhixin Yang iD

Pharmaceutics · 16.07.2026 · 18 (7) · 872

DOI: 10.3390/pharmaceutics18070872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 16.07.2026. Verfasst von Weinan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program for Young Talents of Basic Research in Universities of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The highly heterogeneous and dynamically evolving tumor microenvironment leads to the development of drug resistance and recurrence in traditional therapies. Although immunotherapy demonstrates unique advantages, its clinical utility remains constrained by the suboptimal immunogenicity and the limited effect of monotherapy. Herein, a hybrid drug delivery system based on a spatiotemporal hierarchical controlled-release strategy was proposed to achieve dual immunotherapy with immune checkpoint blockade (ICB) and immunogenic cell death (ICD) to promote synergistic anti-tumor therapy.

Methods

A liposome–micelle hybrid drug delivery system (RUT-RPP-LP) was constructed using a lipid bilayer composed of dioleoyl phosphatidylethanolamine/hemisuccinyl cholesterol to encapsulate rutin (RUT) and to form an inner cavity-encapsulated resveratrol micelle (RPP). RUT-RPP-LP was characterized, and its pH sensitivity and release behavior were investigated. Subsequently, a colon cancer tumor-bearing mouse model was constructed to evaluate the in vivo targeted anti-tumor effect and biological safety. On this basis, the combined mechanism of ICB and ICD was preliminarily explored.

Results

RUT-RPP-LP possessed excellent formulation characteristics, stability, and biocompatibility, achieving graded controlled release of drugs via responding to the TME and lysosomal acidity, respectively. Obviously, RUT-RPP-LP could specifically target the tumor site, induce the occurrence of ICD, and simultaneously block the PD-1/PD-L1 immune checkpoint signaling pathway, thereby enhancing the function of T cells and inducing apoptosis of tumor cells.

Conclusions

The RUT-RPP-LP based on the hierarchical controlled-release strategy exerted a spatiotemporally coordinated enhancement of anti-tumor immunity, and may provide a novel combinatorial approach to overcome the low response of immunotherapy in solid tumors.

Schlagwörter

Stichwörter der Autor:innen

antitumorliposome-micelle hybrid delivery systemresveratrolrutinspatiotemporal hierarchical controlled

Autor:innen und Institutionen

  • School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
  • Key Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Ministry of Education, Harbin 150040, China.

ORCID-Profile: Sisi Yan, Yanhong Wang, Zhixin Yang

Förderung

  • Program for Young Talents of Basic Research in Universities of Heilongjiang Province

Zitieren

APA

Li, W., Yan, S., Gao, Y., Fu, Y., Mei, Y., Wang, Y., & Yang, Z. (2026). Hybrid Drug Delivery System Designed from Spatiotemporal Hierarchical Controlled-Release Strategy Co-Delivering Rutin and Resveratrol for Coordinated Anti-Tumor Immunotherapy. Pharmaceutics, 18(7), 872. https://doi.org/10.3390/pharmaceutics18070872

Vancouver

Li W, Yan S, Gao Y, Fu Y, Mei Y, Wang Y, et al. Hybrid Drug Delivery System Designed from Spatiotemporal Hierarchical Controlled-Release Strategy Co-Delivering Rutin and Resveratrol for Coordinated Anti-Tumor Immunotherapy. Pharmaceutics. 2026;18(7):872. doi:10.3390/pharmaceutics18070872

BibTeX
@article{Li2026,
  author = {Li, Weinan and Yan, Sisi and Gao, Yingying and Fu, Yuhan and Mei, Yutong and Wang, Yanhong and Yang, Zhixin},
  title = {Hybrid Drug Delivery System Designed from Spatiotemporal Hierarchical Controlled-Release Strategy Co-Delivering Rutin and Resveratrol for Coordinated Anti-Tumor Immunotherapy},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {872},
  doi = {10.3390/pharmaceutics18070872}
}
Kostenlos starten →